.-Puromycin and 6-azauridine were used to inhibit protein and ribonucleic acid (RNA) synthesis during Newcastle disease virus replication. Viral RNA, measured by the incorporation of uridine-2-C'4, increased rapidly 6 to 7 hr after infection and reached a peak at 12 hr. Viral RNA synthesis was inhibited by puromycin added at the time of infection or at any time up to 4 hr after infection, but not thereafter. 6-Azauridine (3 mg/ml) inhibited over 90% of the viral RNA synthesis and inhibited protein synthesis to a small extent. Infected cells synthesized more viral RNA than did untreated controls when exposed to azauridine alone for 5 hr, followed by puromycin alone for 9 hr. It was concluded that immediately after virus infection, virus-specific proteins, which are necessary for viral RNA synthesis, were synthesized. Virus-specific protein synthesis may occur even when viral RNA synthesis is greatly inhibited. After virus-specific protein synthesis has taken place, viral RNA synthesis may take place when protein synthesis is almost totally inhibited.
virus infection, virus-specific proteins, which are necessary for viral RNA synthesis, were synthesized. Virus-specific protein synthesis may occur even when viral RNA synthesis is greatly inhibited. After virus-specific protein synthesis has taken place, viral RNA synthesis may take place when protein synthesis is almost totally inhibited.
It has been shown in a number of cases that cells infected with ribonucleic acid (RNA) animal viruses initiate the synthesis of virusspecific proteins prior to, and necessary for, the synthesis of viral RNA. One of these proteins is an RNA-dependent RNA polymerase, which has been found in cells infected with poliovirus (Baltimore et al., 1963) , and Mengo virus (Baltimore and Franklin, 1963a) . It has also been shown that virus-initiated protein synthesis is responsible for the supression of host-cell protein synthesis (Wheelock, 1962; Holland and Peter- son, 1964; Zimmerman, Heeter, and Darnell, 1963; Fenwick, 1963; Martin et al., 1961; Hausen and Verwoerd, 1963; Franklin and Rosner, 1962) .
Following the demonstration by Kingsbury (1962) that actinomycin D could be used to unmask viral RNA synthesis in Newcastle disease virus (NDV)-infected cells, we began this work to study the effect of puromycin, a protein synthesis inhibitor, on synthesis of RNA by NDV. We found that virus-specific protein synthesis must precede viral RNA synthesis. To examine the relationship between RNA and protein synthesis in NDV-infected cells, 6-azauridine (6-AU) was employed to inhibit viral RNA synthesis. Using these inhibitors at different times during NDV replication, we found that virus-initiated protein synthesis would occur in the absence of RNA synthesis, and viral RNA synthesis could occur in the absence of protein synthesis.
MATERIALS AND METHODS Chemicals. Uridine-2-CI4 and leucine-1-C'4 were obtained from New England Nuclear Corp., Boston, Mass. Adenosine-8-C'4 was obtained from Isotope Specialties Co., Burbank, Calif. Puromycin dihydrochloride and 6-AU were obtained from Nutritional Biochemicals Corp., Cleveland, Ohio. We found that puromycin at 60,ug/ml inhibits over 90% of the leucine incorporation in uninfected cells during a 1-hr labeling period, and that greater quantities of puromycin produce no greater inhibition.
Cells and virus. Primary monolayer cultures of chick embryo fibroblasts (CEF) were prepared by trypsinization of 9-day-old decapitated White Leghorn embryos. Cells were grown in Hank's balanced salt solution with 10% calf serum and 0.5% lactalbumin hydrolysate for 48 hr before use. The Texas (GB) strain of NDV was centrifuged and resuspended in phosphate-buffered saline (PBS), pH 6.9. CEF monolayers were washed with PBS, and then virus was added at an average of 200 plaque-forming units per cell. The period of virus adsorption was 30 min. Infected monolayers were incubated with standard medium, which was the same medium used to grow cells, with the addition of 10 ,ug/ml of actinomycin D and C'4-labeled nucleoside or leucine. Actinomycin D was a gift from Karl Pfister, Merck Sharpe and Dohme Research Laboratories.
Analytical procedures. The method of Schmidt and Thannhauser (1945) was used to extract RNA from cells. The incorporation of C14-leucine in protein was measured by the method described by Wheelock (1962) . Radioactivity was measured in a windowless flow counter. To correct for slight variations in the number of cells in CEF monolayers, the ratio of radioactivity to total protein was determined. Protein was determined in the alkali digest step of the SchmidtThannhauser extraction by the method of Lowry et al. (1951) Kingsbury (1962) , who showed, in addition, that the release of infective particles parallels the synthesis of viral RNA. When puromycin was added immediately after infection, viral RNA synthesis was inhibited (Table 1) . Puromycin added 5 hr after infection did not block the synthesis of viral RNA. When puromycin is added at hourly intervals after infection, the puromycin-sensitive process is seen to be nearly complete after about 4 to 5 hr. This result indicates that protein synthesis must occur after infection in order for viral RNA synthesis to occur. We will refer to these proteins, which are synthesized in response to the infecting virus, as virus-specific proteins. It appears that these virus-specific proteins are synthesized in adequate quantity approximately 2 hr before the major increase in viral RNA.
Properties of 6-A U. To determine whether virus-specific protein synthesis may take place in the absence of viral RNA synthesis, an inhibitor was sought which would inhibit viral RNA synthesis without inhibiting protein synthesis. As a result of preliminary studies, 6-AU was chosen for these experiments. Azauridine is an inhibitor of orotidylic acid decarboxylase (Handschumacher, 1960) , and hence prevents N'OL. 88, 1964 
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* 6-AU (1 mg/ml) was added to uninfected chick embryo fibroblast monolayers at 0, 1, or 2 hr before addition of uridine-C14 (0.026 ,uc/ml). All samples were incubated 4 hr with 6-AU and uridine-C14 and then analyzed for radioactivity in the RNA fraction.
t Expressed as counts per minute per milligram. the formation of pyrimidine nucleotides. The effect of 6-AU on uridine and adenosine incorporation in CEF is shown in Table 2 . 6-AU blocks the incorporation of pyrimidine and purine nucleosides into cellular RNA to the same extent. The 6-AU block is accomplished fairly rapidly, since the inhibition of RNA synthesis does not require preincubation with the drug (Table 3) .
6-AU behaves in a similar manner when used to inhibit viral RNA synthesis (Table 4) . The effect of 6-AU on viral RNA synthesis was calculated by taking the ratio of (infected with 6-AU minus uninfected with 6-AU) to (infected minus uninfected). Using this ratio, 6-AU (3 mg/ml) inhibits uridine incorporation into viral RNA by 92% and adenosine incorporation by 95%.
The effect of 6-AU on the incorporation of adenosine-C14 is different from the effect on uridine-C'4 incorporation in uninfected cells exposed to actinomycin D. Actinomycin D alone inhibits approximately 99% of the incorporation of adenosine or uridine in uninfected cells. When uninfected cells exposed to actinomycin D are also exposed to 6-AU, an additional 70% inhibition of uridine incorporation is observed (Table  4) . On the other hand, when uninfected cells are exposed to actinomycin D and 6-AU, the incorporation of adenosine is enhanced about 70 % over the incorporation with actinomycin alone.
The inhibition of uridine incorporation in viral RNA by 6-AU could be interpreted as a result of competition between the two compounds for sites in the newly forming RNA molecules, or as a result of inhibition of orotidylic acid decarboxylase. If the first interpretation were correct, then new viral RNA would be synthesized, but with azauracil substituted for uracil. The second interpretation leads to the conclusion that no RNA would be synthesized, owing to the reduced cellular pools of pyrimidine nucleotides. Since 6-AU at a given level produces a comparable level of inhibition of cellular and viral RNA synthesis, and inhibits both uridine and adenosine incorporation into viral RNA to the same extent, it is assumed that 6-AU inhibits viral RNA synthesis at the same level at which cellular RNA synthesis is blocked.
The incorporation of uridine in RNA of infected cells (Table 4) The effect of 6-AU on cellular protein synthesis was measured by incubating uninfected CEF monolayers for 5 hr with 6-AU, actinomycin D (10 ,ug/ml), and leucine-C14 (0.17 ,c/ml). The incorporation in control cultures without 6-AU was 1,749 counts per min per mg. In the presence of 3 mg/ml of 6-AU, the incorporation was 1,019 counts per min per mg, which amounts to a 41 % inhibition of protein synthesis. The 6-AU block to RNA synthesis rapidly disappears when the drug is removed (Table 5 ). The rate of RNA synthesis in cells preincubated with 6-AU was higher than untreated control values during the first hour after the drug was removed. After that, radioactive RNA increased in both samples at the same rate.
Inhibition of viral RNA synthesis by puromycin and 6-A U. CEF monolayers infected with NDV were incubated, starting immediately after infection, with 6-AU. At various times, the 6-AU was removed and the incubation was continued with standard medium. The experiment lasted 12 hr. The results shown in Table 6 indicate that the extent of inhibition of viral RNA synthesis increases as the time with 6-AU increases, as was expected.
Since 6-AU and puromycin exert their primary effects on different stages in the viral growth cycle, an experiment was conducted in which cells were exposed to 6-AU for the first 5 hr after infection, then washed, and incubated with puromycin for the next 9 hr (Table 7) . When * Infected and uninfected chick embryo fibroblast monolayers were overlaid with medium containing 3 mg/ml of 6-AU immediately after infection (except controls which received no 6-AU). At different times after infection, monolayers were washed twice to remove 6-AU and incubation was continued with standard medium. All samples were incubated 12 hr and all media contained 0.031 ,uc of uridine-C14 and actinomycin D (10,lg/ml). * Chick embryo fibroblast monolayers were incubated for 5 hr (with or without drugs) in standard medium, washed twice, and incubated for an additional 9 hr (with or without drug) in medium containing actinomycin D (10 ,ug/ml> and 0.12 ,uc/ml of uridine-C14. Pu = 60,ug/ml of puromycin; 6-AU = 3 mg/ml of azauridine;-= uninfected; + = infected.
t Expressed as counts per minute per milligram.
6-AU was present for the first 5 hr, followed by standard medium for 9 hr, viral RNA synthesis was inhibited by 15%. When infected cells were exposed to standard medium for 5 hr and incubated with puromycin for 9 hr, viral RNA synthesis was enhanced considerably over control values. Infected cells, exposed to 6-AU for 5 hr followed by puromycin for 9 hr, synthesized more viral RNA than controls and about 70% as much viral RNA as samples exposed only to puromycin for the last 9 hr. The effect of 6-AU may be due to the direct inhibition of virus-specific protein synthesis, or of early RNA synthesis, which gives rise to templates for protein synthesis.
Our results indicate that viral RNA synthesis will not occur in infected cells unless some virusspecific protein synthesis takes place after infection. When infected cells are exposed to 6-AU for 5 hr, followed by puromycin for 9 hr, viral RNA synthesis proceeds at a nearly normal rate. This result indicates that virus-specific protein synthesis may continue at an essentially normal level, even when RNA synthesis has been greatly inhibited. We find that, after the synthesis of virus-specific proteins, viral RNA synthesis occurs in the presence of puromycin, indicating that viral RNA synthesis can take place when protein synthesis is almost totally inhibited. This result also indicates that virus-specific protein synthesis and viral RNA synthesis may occur at different times during replication.
DISCUSSION
We have indicated that viral RNA synthesis occurs in the presence of puromycin at concentrations which inhibit protein synthesis. NDV differs from poliovirus in this respect, since polio RNA synthesis stops shortly after protein synthesis is inhibited (Levintow et al., 1962) . This result is taken to mean that the poliovirusinduced RNA polymerase is unstable. Our results do not indicate that the NDV-specific proteins necessary for viral RNA synthesis are unstable.
Since protein synthesis must precede viral RNA synthesis in NDV-infected cells, we may assume that all the necessary proteins were not present in an active form in the cells before infection. It has been shown that poliovirus RNA polymerase is formed de novo after infection (Baltimore and Franklin, 1963b) . The puromycinsensitive phase, which is the period of virusspecific protein synthesis, ends 4 to 5 hr after infection. This is approximately 2 hr earlier than the time (between 6 to 7 hr) during which the most rapid increase in viral RNA synthesis takes place. With both poliovirus and Mengo virus, the time of appearance and rate of increase of RNA-dependent RNA polymerase closely parallels the synthesis of viral RNA (Baltimore and Franklin, 1963b) .
The fact that RNA synthesis is not required for virus-specific protein synthesis is consistent with a number of observations which indicate that viral RNA acts as a messenger to direct the synthesis of proteins which are necessary for its replication. In both poliovirus-infected cells (Penman et al., 1963) and Mengo virus-infected cells (Tobey, 1964b) , viral RNA is found associated with polyribosomal structures. Most of the poliovirus-specific RNA, protein, and newly formed virus is also found associated with these polysomes (Penman, Becker, and Darnell, 1964) . Viral RNA acts as messenger RNA, directing the synthesis of virus-specific proteins in in vitro protein-synthesizing systems (Tsugita et al., 1962; Nathans et al., 1962) .
If, as we suppose, viral RNA from NDV provides the information for viral-directed protein synthesis, then we may ask whether this RNA acts directly as the messenger or as a template for messengers. The synthesis of virusspecific proteins in the presence of 6-AU is taken as an indication that viral RNA itself, and not a complimentary strand, serves as the messenger. Penman et al. (1964) arrived at a similar conclusion for poliovirus.
For the infecting virus RNA to serve, first, as a template for protein synthesis, and then as a template for RNA synthesis, there must be no degradation of the RNA during the protein synthesis step. It has been demonstrated that the physical and biological integrity of Mengo virus (Tobey, 1964a) and phage MS42 RNA (Doi and Spiegelman, 1963 ) is conserved during viral replication.
Our results provide no direct evidence for conservation of NDV RNA through the entire period of replication, but do indicate that the infecting virus RNA is still capable of acting as a template for new RNA synthesis 5 hr after infection. Since RNA synthesis is blocked during this period and virus-specific proteins are synthesized, it is concluded that virus-specific protein synthesis does not result in degradation of NDV RNA.
